Об авторах
Арсентьева Наталья АлександровнаФБУН «НИИ эпидемиологии и микробиологии им. Пастера», Роспотребнадзор 197101, г. Санкт-Петербург, Россия arsentieva_n.a@bk.ru
Список литературы
ВОЗ. Информационный бюллетень № 164. Доступен на: https://www.who.int/mediacentre/factsheets/fs164/ru/
Соринсон С.Н., Селиванов Н.А., Корочкина О.В. Гепатит С: механизмы многолетней персистенции вируса и фазы инфекционного процесса. Клиническая медицина. 1997; 75 (10): 27-30.
Alter H.J., Seff L.B. Recovery, persistence, and sequelae in hepatitis C virus. Seminars in liver disease. 2000; 20 (1): 17-35.
Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR , CLINIVIR and DOSVIRC groups. Lancet. 1997; 349 (9055): 825-32.
Михайлов М. И. Лабораторная диагностика гепатита С (Серологические маркеры и методы их выявления). Вирусные гепатиты: достижения и перспективы. 2001. Доступен на: https://medi.ru/doc/08h1202.htm.
Sarobe P., Lasarte J.J., Zabaleta A., Arribillaga L., Arina A., Melero I., Borrás-Cuesta F., Prieto J. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. Virology. 2003; 77 (20): 10 862-71.
Giboney P.T. Mildly Elevated liver transaminase levels in the asymptomatic patient. American Family Physician. 2005; 71 (6): 1105-10.
Apolinario A., Diago M., Lo Iacono O. Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy. Alimentary Pharmacology & Therapeutics. 2004; 19: 551-62.
Van Damme J., Mantovani A. From cytokines to chemokines. Cytokine & Growth Factor Reviews. 2005; 16: 549-51.
Esche C., Stellato C., Beck L.A. Chemokines: key players in innate and adaptive immunity. Investigative Dermatology. 2005; 125: 615-28.
Lechner F., Wong D.K., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P., Robbins G., Phillips R., Klenerman P., Walker B.D. Analysis of successful immune responses in persons infected with hepatitis C virus. Experimental Medicine. 2000; 191 (9): 1499-512.
Larrubia J.R., Benito-Martínez S., Calvino M., Sanz-de-Villalobos E., Parra-Cid T. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World Journal of Gastroenterology. 2008; 14: 7149-59.
Chomczynski P., Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nature Protocols. 2006; 1: 581-5.
Mantovani A. The chemokine system: redundancy for robust outputs. Immunology Today. 1999; 20 (6): 469-73.